Griseofulvin is an active pharmaceutical ingredient (API) with a structure that includes aromatic and ether functional groups. It is characterized by a metastable polymorph that exhibits anomalously large thermal expansion, as studied from the melt.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 126-07-8
Mitapivat
pharmaceutical raw material
TAK 438
pharmaceutical raw material
Δ14-triamcinolone acetonide
pharmaceutical raw material
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
pharmaceutical raw material
The international HS code for Griseofulvin (CAS 126-07-8) is 2941.90.
2941.90
2941 90 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
DDUHZTYCFQRHIY-RBHXEPJQSA-N
C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC